在患有高脂蛋白水平的患者中评估降脂疗法
Michael S Kelly1, Ruth N Jeminiwa1, Fatima Gohar1
1Thomas Jefferson University College of Pharmacy, Jefferson College of Pharmacy, Philadelphia, PA, USA (Drs Kelly, and Jeminiwa; Gohar, Fanous, and Ramirez).
Journal of clinical lipidology
|June 4, 2025
概括
不到四分之一的患有高脂蛋白 (Lp) 的患者进行了加剧的降脂疗法. 升高的LDL-C预测了药物变化,但需要对Lp降低策略进行进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 临床脂质学 临床脂质学
- 药物治疗 药物治疗
背景情况:
- 升高的脂蛋白 (Lp) 是动脉样硬化心血管疾病 (ASCVD) 的关键独立风险因素.
- 对高Lp的患者来说,管理可修改的ASCVD风险因素,如高血压和脂质失调,至关重要.
- 目前的临床实践修改降脂疗法,以应对升高的Lp (a) 并没有充分记录.
研究的目的:
- 分析患有升高Lp的患者中降脂疗法的变化.
- 为了确定与强化降脂药物相关的患者特征.
主要方法:
- 追溯性,观察性病例控制研究设计.
- 对Lp (a) ≥30 mg/dL (75 nmol/L) 的患者的降脂疗法修改的分析.
- 从2020年1月1日到2024年5月31日收集的数据.
主要成果:
- 在539名符合条件的患者中,120名 (22.3%) 在Lp (a) 结果升高后的30天内经历了治疗修改.
- 最常见的干预措施包括添加ezetimibe (33.3%) 和加强他类药物治疗 (32.5%).
- 升高的低密度脂蛋白胆固醇 (LDL-C) 是脂质药物改变的最强预测因素.
结论:
- 降脂药物强化发生在不到25%的患者中,Lp (a) 升高在30天内.
- 需要进一步的研究来比较积极的LDL-C降低与Lp (a) 降低在该患者群体中预防ASCVD的疗效.
相关概念视频
01:26Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
890
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
890
01:30Atherosclerosis I: Introduction
97
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
97
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
301
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
301
01:23Atherosclerosis IV: Nursing Management
69
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
69
01:26Angina IV: Management
32
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
32